• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双调蛋白可削弱p53过表达诱导的肝癌细胞凋亡中的凋亡刺激蛋白2。

Amphiregulin impairs apoptosis-stimulating protein 2 of p53 overexpression-induced apoptosis in hepatoma cells.

作者信息

Liu Kai, Lin Dongdong, Ouyang Yabo, Pang Lijun, Guo Xianghua, Wang Shanshan, Zang Yunjin, Chen Dexi

机构信息

1 Beijing Institute of Hepatology, Capital Medical University affiliated Beijing You An Hospital, Beijing, P.R. China.

2 Capital Medical University affiliated Beijing You An Hospital, Beijing, P.R. China.

出版信息

Tumour Biol. 2017 Mar;39(3):1010428317695026. doi: 10.1177/1010428317695026.

DOI:10.1177/1010428317695026
PMID:28351301
Abstract

Overexpression of apoptosis-stimulating protein 2 of p53 (ASPP2) induces apoptotic cell death in hepatoma cells (e.g. HepG2 cells) by enhancing the transactivation activity of p53, but long-term ASPP2 overexpression fails to induce more apoptosis since activation of the epidermal growth factor/epidermal growth factor receptor/SOS1 pathway impairs the pro-apoptotic role of ASPP2. In this study, in recombinant adenovirus-ASPP2-infected HepG2 cells, ASPP2 overexpression induces amphiregulin expression in a p53-dependent manner. Although amphiregulin initially contributes to ASPP2-induced apoptosis, it eventually impairs the pro-apoptotic function of ASPP2 by activating the epidermal growth factor/epidermal growth factor receptor/SOS1 pathway, leading to apoptosis resistance. Moreover, blocking soluble amphiregulin with a neutralizing antibody also significantly increased apoptotic cell death of HepG2 cells due to treatment with methyl methanesulfonate, cisplatin, or a recombinant p53 adenovirus, suggesting that the function of amphiregulin involved in inhibiting apoptosis may be a common mechanism by which hepatoma cells escape from stimulus-induced apoptosis. Thus, our data elucidate an apoptosis-evasion mechanism in hepatocellular carcinoma and have potential implications for hepatocellular carcinoma therapy.

摘要

p53凋亡刺激蛋白2(ASPP2)的过表达通过增强p53的反式激活活性诱导肝癌细胞(如HepG2细胞)发生凋亡性细胞死亡,但长期ASPP2过表达未能诱导更多凋亡,因为表皮生长因子/表皮生长因子受体/SOS1途径的激活损害了ASPP2的促凋亡作用。在本研究中,在重组腺病毒-ASPP2感染的HepG2细胞中,ASPP2过表达以p53依赖的方式诱导双调蛋白表达。虽然双调蛋白最初有助于ASPP2诱导的凋亡,但它最终通过激活表皮生长因子/表皮生长因子受体/SOS1途径损害ASPP2的促凋亡功能,导致凋亡抗性。此外,用中和抗体阻断可溶性双调蛋白也显著增加了甲磺酸甲酯、顺铂或重组p53腺病毒处理导致的HepG2细胞凋亡性细胞死亡,提示双调蛋白参与抑制凋亡的功能可能是肝癌细胞逃避刺激诱导凋亡的常见机制。因此,我们的数据阐明了肝细胞癌中的一种凋亡逃避机制,对肝细胞癌治疗具有潜在意义。

相似文献

1
Amphiregulin impairs apoptosis-stimulating protein 2 of p53 overexpression-induced apoptosis in hepatoma cells.双调蛋白可削弱p53过表达诱导的肝癌细胞凋亡中的凋亡刺激蛋白2。
Tumour Biol. 2017 Mar;39(3):1010428317695026. doi: 10.1177/1010428317695026.
2
Nuclear EGFR impairs ASPP2-p53 complex-induced apoptosis by inducing SOS1 expression in hepatocellular carcinoma.细胞核表皮生长因子受体(EGFR)通过诱导肝细胞癌中SOS1的表达来损害ASPP2-p53复合物诱导的细胞凋亡。
Oncotarget. 2015 Jun 30;6(18):16507-16. doi: 10.18632/oncotarget.3757.
3
ASPP2 enhances chemotherapeutic sensitivity through the down-regulation of XIAP expression in a p53 independent manner in hepatocellular carcinoma.ASPP2 通过独立于 p53 的方式下调 XIAP 表达增强肝癌对化疗的敏感性。
Biochem Biophys Res Commun. 2019 Jan 15;508(3):769-774. doi: 10.1016/j.bbrc.2018.11.181. Epub 2018 Dec 6.
4
Exogenous p53 and ASPP2 expression enhances rAdV-TK/ GCV-induced death in hepatocellular carcinoma cells lacking functional p53.外源性p53和ASPP2表达增强了rAdV-TK/GCV对缺乏功能性p53的肝癌细胞的诱导死亡作用。
Oncotarget. 2016 Apr 5;7(14):18896-905. doi: 10.18632/oncotarget.7749.
5
Synergistic inhibitory effects on hepatocellular carcinoma with recombinant human adenovirus Aspp2 and oxaliplatin via p53-independent pathway in vitro and in vivo.重组人腺病毒 Aspp2 和奥沙利铂通过 p53 非依赖性途径在体外和体内协同抑制肝癌。
Int J Oncol. 2017 Oct;51(4):1291-1299. doi: 10.3892/ijo.2017.4105. Epub 2017 Aug 29.
6
CHOP mediates ASPP2-induced autophagic apoptosis in hepatoma cells by releasing Beclin-1 from Bcl-2 and inducing nuclear translocation of Bcl-2.CHOP通过从Bcl-2释放Beclin-1并诱导Bcl-2核转位,介导ASPP2诱导的肝癌细胞自噬性凋亡。
Cell Death Dis. 2014 Jul 17;5(7):e1323. doi: 10.1038/cddis.2014.276.
7
The effect of adenovirus-conjugated NDRG2 on p53-mediated apoptosis of hepatocarcinoma cells through attenuation of nucleotide excision repair capacity.腺病毒缀合 NDRG2 通过减弱核苷酸切除修复能力对肝癌细胞 p53 介导的细胞凋亡的影响。
Biomaterials. 2014 Jan;35(3):993-1003. doi: 10.1016/j.biomaterials.2013.09.096.
8
A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.一种新型全反式维甲酸衍生物4-氨基-2-三氟甲基苯基维甲酸酯通过上调p53和ASPP1以及下调iASPP诱导G0/G1期细胞周期阻滞和凋亡,从而抑制人肝癌HepG2细胞的增殖。
Oncol Rep. 2016 Jul;36(1):333-41. doi: 10.3892/or.2016.4795. Epub 2016 May 9.
9
Protective effects of hepatic stellate cells against cisplatin-induced apoptosis in human hepatoma G2 cells.肝星状细胞对顺铂诱导的人肝癌G2细胞凋亡的保护作用。
Int J Oncol. 2015 Aug;47(2):632-40. doi: 10.3892/ijo.2015.3024. Epub 2015 May 28.
10
Diosmetin induces apoptosis by upregulating p53 via the TGF-β signal pathway in HepG2 hepatoma cells.香叶木素通过TGF-β信号通路上调p53,从而诱导HepG2肝癌细胞凋亡。
Mol Med Rep. 2016 Jul;14(1):159-64. doi: 10.3892/mmr.2016.5258. Epub 2016 May 12.

引用本文的文献

1
TP53BP2: Roles in suppressing tumorigenesis and therapeutic opportunities.TP53BP2:在抑制肿瘤发生中的作用及治疗机会
Genes Dis. 2022 Sep 5;10(5):1982-1993. doi: 10.1016/j.gendis.2022.08.014. eCollection 2023 Sep.
2
Mir-30b-5p Promotes Proliferation, Migration, and Invasion of Breast Cancer Cells via Targeting ASPP2.miR-30b-5p 通过靶向 ASPP2 促进乳腺癌细胞的增殖、迁移和侵袭。
Biomed Res Int. 2020 Apr 29;2020:7907269. doi: 10.1155/2020/7907269. eCollection 2020.
3
Dickkopf-1 and Amphiregulin as Novel Biomarkers and Potential Therapeutic Targets in Hepatocellular Carcinoma.
Dickkopf-1和双调蛋白作为肝细胞癌的新型生物标志物和潜在治疗靶点
Int J Hematol Oncol Stem Cell Res. 2019 Jul 1;13(3):153-163.